Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Rhenman & Partners Asset Management AB
Form 13F · Q2 2026

Rhenman & Partners Asset Management AB

CIK 1599882Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$1.1B
Reported book value
99
Positions
12
Quarters on record
Top 50
Positions

Rhenman & Partners Asset Management AB — holdings

Top 50 positions of 99, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1UNH Unitedhealth Group Inc93,600+105.7%$39M3.7%
2CVS Cvs Health Corp279,374−17.0%$29M2.7%
3AZN Astrazeneca Plc151,500—$28M2.7%
4MRK Merck & Co Inc213,500—$27M2.6%
5LLY Eli Lilly & Co22,315−33.8%$27M2.5%
6ABBV Abbvie Inc96,775+35.2%$24M2.3%
7ALHC Alignment Healthcare Inc997,083−5.4%$24M2.2%
8EW Edwards Lifesciences Corp260,000+59.5%$24M2.2%
9GILD Gilead Sciences Inc178,250+6.3%$23M2.1%
10JAZZ Jazz Pharmaceuticals Plc87,440+15.2%$21M2.0%
11BIIB Biogen Inc94,850−13.1%$20M1.9%
12SYK Stryker Corporation65,000+36.0%$20M1.9%
13BSX Boston Scientific Corp450,500−27.9%$19M1.8%
14JNJ Johnson & Johnson72,500—$18M1.7%
15GH Guardant Health Inc115,000−20.7%$17M1.6%
16REGN Regeneron Pharmaceuticals27,390−43.1%$17M1.6%
17GKOS Glaukos Corp119,000+41.7%$17M1.6%
18BMRN Biomarin Pharmaceutical Inc290,500+40.3%$17M1.6%
19NRIX Nurix Therapeutics Inc684,250+118.3%$17M1.6%
20NTRA Natera Inc61,050+18.3%$17M1.6%
21MIRM Mirum Pharmaceuticals Inc139,205+50.3%$16M1.5%
22INSM Insmed Inc151,960−4.9%$16M1.5%
23THC Tenet Healthcare Corp85,200+57.8%$16M1.5%
24TMO Thermo Fisher Scientific Inc31,580−23.6%$16M1.5%
25CNC Centene Corp Del244,000—$16M1.5%
26AXSM Axsome Therapeutics Inc.63,050−1.2%$15M1.5%
27DANAHER CORP DEL Danaher Corp Del80,252+344.6%$15M1.4%
28VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc30,685−29.4%$15M1.4%
29AVR Anteris Technologies Global1.5M+7.0%$15M1.4%
30NBIX Neurocrine Biosciences Inc85,841−14.9%$14M1.4%
31PNTG Pennant Group Inc371,471+34.9%$14M1.3%
32ISRG Intuitive Surgical Inc34,500−6.4%$14M1.3%
33ELV Elevance Health Inc Formerly34,900+8.0%$13M1.3%
34LIVN Livanova Plc164,000+5.8%$13M1.3%
35COR Cencora Inc46,778−10.7%$13M1.2%
36CHARLES RIV LABS INTL INC Charles Riv Labs Intl Inc57,200+120.0%$13M1.2%
37IDYA Ideaya Biosciences Inc343,800+34.6%$13M1.2%
38MCK Mckesson Corp16,550−1.8%$13M1.2%
39SNDX Syndax Pharmaceuticals Inc560,250+47.7%$12M1.2%
40BRIGHTSPRING HEALTH SVCS INC Brightspring Health Svcs Inc165,896+231.8%$12M1.1%
41MDT Medtronic Plc145,000+61.1%$11M1.1%
42MLYS Mineralys Therapeutics Inc416,371+58.3%$11M1.1%
43OSCR Oscar Health Inc392,000−40.6%$11M1.1%
44RPRX Royalty Pharma Plc197,000−15.5%$11M1.0%
45DXCM Dexcom Inc160,000—$11M1.0%
46ALGN Align Technology Inc63,000+740.0%$11M1.0%
47SYRE Spyre Therapeutics Inc119,300—$11M1.0%
48RLAY Relay Therapeutics Inc566,000+57.2%$11M1.0%
49ARWR Arrowhead Pharmaceuticals In128,000−11.4%$10M1.0%
50A Agilent Technologies Inc75,000+200.0%$10M0.9%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.